Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccineArticle Published on 2023-01-152023-07-11 Journal: Journal of the neurological sciences [Category] [DOI] 10.1016/j.jns.2022.120518 PMC 바로가기
COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issuesArticle Published on 2022-12-012023-07-11 Journal: Drugs of today (Barcelona, Spain : 1998) [Category] [DOI] 10.1358/dot.2022.58.12.3455368 PMC 바로가기
Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infectionResearch article Published on 2022-11-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] [DOI] 10.1016/j.msard.2022.104067 [Article Type] Research article
SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19다발성 경화증 환자의 SARS-CoV-2 감염: COVID-19에 대한 치료법, 보조 요법 및 백신과의 상호 작용Review Published on 2022-09-012022-09-11 Journal: Journal of Neurology [Category] [DOI] 10.1007/s00415-022-11237-1 PMC 바로가기 [Article Type] Review
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis질병 조절 요법 후 다발성 경화증 환자에서 COVID-19 예방 접종의 반응: 메타 분석Meta-Analysis Published on 2022-07-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.104102 PMC 바로가기 [Article Type] Meta-Analysis
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis다발성 경화증 환자의 항-COVID19 백신 접종에 대한 항체 매개 반응에 대한 질병 조절 치료의 효과Article Published on 2022-06-012022-09-11 Journal: Journal of Neurology [Category] [DOI] 10.1007/s00415-022-11003-3 PMC 바로가기 [Article Type] Article
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational studyObservational Study Published on 2022-06-012023-07-09 Journal: Multiple sclerosis (Houndmills, Basingstoke, Engla [Category] [DOI] 10.1177/13524585221092309 PMC 바로가기 [Article Type] Observational Study
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in ItalyBNT162b2 백신 후 다발성 경화증 환자의 Anti-Spike IgG: 이탈리아의 탐색적 사례 대조 연구Multicenter Study Published on 2022-02-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] [DOI] 10.1016/j.msard.2021.103415 PMC 바로가기 [Article Type] Multicenter Study
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies다양한 질병 조절 요법으로 치료받는 다발성 경화증 환자에서 mRNA COVID-19 백신의 면역원성과 안전성Article Published on 2022-01-012022-09-11 Journal: Neurotherapeutics : the journal of the American So [Category] [DOI] 10.1007/s13311-021-01165-9 PMC 바로가기 [Article Type] Article
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccineBBIBP-CorV(Sinopharm) 비활성화 바이러스 백신 접종 후 질병 조절 요법을 받는 다발성 경화증 환자의 SARS-CoV-2 혈청학: 같은 이야기, 다른 백신Article Published on 2022-01-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] [DOI] 10.1016/j.msard.2021.103417 PMC 바로가기 [Article Type] Article